May 2, 2024Open Access

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

Key Points

Key points are not available for this paper at this time.

Abstract

To investigate the correlation between programmed death ligand 1(PD-L1), tumor mutation burden (TMB) and the short-term efficacy and clinical characteristics of anti-PD-1 immune checkpoint inhibitor combination chemotherapy in NSCLC patients. The efficacy of the prediction model was evaluated.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Shuling Shi

Yingyi Wang

Jingjing Wu

Journals

Frontiers in Oncology

Actions

Institutions

Zhengzhou University

First Affiliated Hospital of Zhengzhou University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider